Recent study from Japan confirms the value of original GastroPanel® biomarkers diagnosis of autoimmune atrophic gastritis.
Biohit Oyj press release 9.5.2022 at 14.00 local time (EEST) The publisher of the topmost medical journal Nature (1) reported recently a study that evaluated the accuracy of serological testing for the biomarkers (pepsinogens and gastrin) in diagnosis of autoimmune atrophic gastritis (AAG) (1). This cross-sectional study provides results that are similar as recently reported by Biohit partners in a population-based screening setting, where GastroPanel® showed unrivalled test characteristics in non-invasive screening of asymptomatic healthy people for AAG (2). AAG is